Clearly The Systems That Approve Individuals To Be Employed In NSW Health Are Failing!

This report appeared today:

This appeared this morning

NSW Health nurses suspended over antisemitic video

Paul Karp NSW political correspondent

Feb 12, 2025 – 11.48am

Two nurses at Sydney’s Bankstown hospital have been stood down by NSW Health after an antisemitic video emerged online of them claiming they would refuse to treat and would kill Israeli patients.

State Health Minister Ryan Park said the video was the most “vile, shocking and appalling video” he had ever seen, and would be investigated by both NSW Health and the NSW Police, including for potential breach of hate speech laws. Police confirmed that Strike Force Pearl was investigating.

The NSW Health Department has called in police after footage surfaced appearing to show Bankstown Hospital workers bragging about killing Israeli patients.

In the video, a woman in a NSW Health uniform claims that she “won’t treat” Israeli patients and would “kill them”, while a man who falsely identified himself as a doctor said he had “literally sent” Israel patients to “jahannam” (hell).

Mr Park said the two had been identified and stood down just hours after the video – believed to have been taken during a night shift on Tuesday evening or Wednesday morning – was shown to the government.

At a media conference at NSW parliament, Mr Park addressed the Jewish community, saying he was “very sorry” and promising the two nurses “will not ever be working for NSW Health again”.

“There is no place in our hospitals or health system for this sort of view to ever take place.”

The investigation includes a referral to the Health Care Complaints Commission, to include the standard of care the hospital and nurses have given patients.

But Mr Park said that after an initial rapid review of patient incidents, the hospital appeared to be operating with the proper level of safety and care of patients.

NSW Health Minister Ryan Park says two hospital workers filmed making antisemitic comments and bragging about killing Israeli patients have been stood down, with a police investigation now under way.

The video was published by a Jewish influencer who encouraged followers to share it to ensure the nurses he interviewed were fired. “There’s no way such people should work in medicine,” he said in the video.

In the video the woman tells the influencer, “It’s Palestine’s country, not your country you piece of shit.” The man says: “I’m a doctor, my man, in a hospital. You’re going to get killed and you’re going to go to jahannam, inshallah [God willing].”

Premier Chris Minns said the video was “hugely distressing” and would be met with a full response from NSW Health and NSW Police.

He told 2GB Radio the pair “will not be back in the NSW Health system” but a full investigation was required to make sure “there’s not a glimmer of hope of some kind of administrative turnback”.

NSW Health secretary Susan Pearce condemned “in the strongest possible terms” the behaviour of the two nurses. “Never in my wildest dreams did I think I would be standing here with two staff members of NSW Health system having said such horrendous things about our community, particularly our Jewish community.”

Federal Health Minister Mark Butler, said the video “makes me sick to my stomach”.

“The idea that you would single out a particular group in our community and indicate you wouldn’t care for them runs against every single principle in our healthcare system,” Mr Butler said in a statement.

“At a time of unprecedented antisemitism in our country, this is a particularly sickening video.”

– with Tom McIlroy

 Here is the link:

https://www.afr.com/policy/foreign-affairs/nsw-health-nurses-suspended-over-antisemitic-video-20250212-p5lbh1

What a lovely pair! I am amazed to see such hate-filled material from health professionals in Australia. Pretty sad to say the least!

This pair really should go back to where they came from! They are not worthy of living here IMVHO!

David.

It Makes Good Sense To Help Individuals Lose Weight If The Are Significantly Overweight

This appeared last week:

Big pharma steps up push for taxpayer-funded weight-loss drugs

Michael Smith Health editor

Feb 9, 2025 – 1.00pm

Novo Nordisk and Eli Lilly have asked the federal government to list their blockbuster weight-loss drugs on the Pharmaceutical Benefits Scheme, arguing funding the treatment will reduce a costly obesity crisis.

Novo Nordisk, the Danish pharmaceutical giant that makes Ozempic and Wegovy, used a submission to the government’s budget process to push for the inclusion of so-called GLP-1 drugs on the PBS for chronic weight management. It said not doing so would be more expensive in the long term.

“Novo Nordisk recommends decisive action, including increased investment in health promotion, integrated disease prevention and care, and expanded access to pharmacotherapy. The cost of inaction is far greater than the cost of intervention,” the company said in its submission.

Eli Lilly, the American company that makes a rival weight-loss drug called Mounjaro, has also called for the obesity drugs to be listed on the PBS in its pre-budget submission. The Eli Lilly submission has not been made public, but people briefed on its contents confirmed the inclusion.

A PBS listing means the government subsidises most of the cost of a drug. Ozempic is listed on the PBS but only to treat people with diabetes rather than obesity. Novo Nordisk plans to resubmit an application to have Wegovy listed with the Pharmaceutical Benefits Advisory Committee, this year.

Pharmaceutical companies argued there were economic benefits to improving access to the drugs, which sell for between $345 and $645 per month, because a reduction in the number of obese people would take the pressure off the health system in the future.

Novo Nordisk last week reported a 29 per cent increase in fourth-quarter earnings to 28.23 billion Danish kroner ($6.3 billion) as sales of Wegovy jumped 107 per cent year-on-year. Eli Lilly on Friday said fourth-quarter sales surged 45 per cent to $US13.53 billion ($21.5 billion). The companies do not break down sales data for specific countries, including Australia.

Novo Nordisk’s pre-budget submission said chronic disease was the leading health challenge in Australia, affecting 61 per cent of the population and accounting for 91 per cent of preventable deaths. Its submission said obesity was a major contributor and 6.3 million Australians were obese, with the number expected to rise to 47 per cent of adults by 2035.

Doctors say while the drugs are proven to help people lose weight there is still a lot they do not know about the long-term effects of managing fat chemically and that it is important to lead a healthy and active lifestyle. The drugs are taken once a week by an injection.

The latest move by the drug companies reopens the debate about whether taxpayers should subsidise the new class of medicines. Last year, Mounjaro was made available on Britain’s public healthcare system to some patients.

Jonathan Karnon, a health economist at Flinders University, said it would be more difficult to convince the Australian government because of the way that subsidising those drugs would affect the federal budget.

“It will be interesting to see what happens in England because it affects local budgets, whereas in Australia, it affects the Commonwealth government’s budget and so the effect on the budget is of greater concern to those making decisions about whether the GLP-1s should be funded,” he said.

‘Unaffordable for many Australians’

Patients groups said GLP-1s were unaffordable for most Australians and some funding should be provided.

“Given that GLP1-s remain unaffordable for many Australians who could benefit from them, some form of government-funded access needs to be on the horizon. That said, government funding must remain contingent on the usual processes assessing value for money against benefit to patients,” Lisa Robins, chief executive of the Australian Patients Association said.

Woolworths-backed telehealth business Eucalyptus, which has earned more than $100 million from weight-loss services over the past 18 months from its operations in Australia, Japan, the United Kingdom and Germany, said a PBS listing was needed to tackle obesity in Australia.

“As we have seen recently, the Australian Institute of Health and Welfare has released figures showing that for the first time obesity has surpassed smoking as the leading risk factor contributing to death. This underlines the importance of ensuring patients have access to care,” Matt Vickers, the clinical director of Eucalyptus subsidiary Juniper said.

While a PBS listing could be restricted to a defined group of obese people with related health risks or the number of subscriptions capped, the popularity of the drugs and their wide use means government bureaucrats will be wary of approving a listing that could potentially bankrupt public healthcare systems if too many people wanted them.

Academics studying the take-up of GLP-1s said the lack of hard data on how many Australians were taking them was alarming, but they estimated the numbers were in the hundreds of thousands. Studies in the US suggest that between 8 per cent and 12 per cent of Americans are taking them.

Michael Smith is the health editor for The Australian Financial Review. He is based in Sydney. Connect with Michael on Twitter. Email Michael at michael.smith@afr.com

Here is the link:

https://www.afr.com/companies/healthcare-and-fitness/big-pharma-steps-up-push-for-taxpayer-funded-weight-loss-drugs-20250206-p5la1a

All this raises a lot of issues in my mind about the mass medication of a large number of people and just how both the costs and the side-effects would be managed.

There is certainly a strong case for use in the significantly obese as this will save lives etc. but how the costs (which will be significant) and the allocation of these meds will be managed will be a real challenge I suspect. Many clever bureaucrats will have to work out how all this will work given the large scale need, and the costs involved.

A real watch this space moment!

David.

I Have The Sense That The US System Of Government Is In For A Pretty Major Stress Test!

This appeared a day or so ago….

Judge extends brake on Musk’s Treasury raid, summons Trump to court

Hurubie Meko and Qasim Nauman

Feb 9, 2025 – 10.41am

A US federal judge in New York has temporarily restricted access by Elon Musk’s government efficiency program to the Treasury Department’s payment and data systems, saying there was a risk of “irreparable harm”.

The Trump administration’s new policy of allowing political appointees and “special government employees” access to these systems, which contain highly sensitive information such as bank details, heightens the risk of leaks and of the systems becoming more vulnerable than before to hacking, US District Judge Paul Engelmayer said in an emergency order late on Saturday (Sunday AEDT).

Judge Engelmayer ordered any such official who had been granted access to the systems since January 20 to “destroy any and all copies of material downloaded from the Treasury Department’s records and systems”. He also restricted the Trump administration from granting access to those categories of officials.

The defendants – President Donald Trump, Treasury Secretary Scott Bessent and the Treasury Department – must appear in February before Judge Jeannette Vargas, who is handling the case on a permanent basis, Judge Engelmayer said.

The White House called the ruling “absurd and judicial overreach” and attacked the judge as an “activist”.

“Grandstanding government efficiency speaks volumes about those who’d rather delay much-needed change with legal shenanigans than work with the Trump administration,” Harrison Fields, a spokesman, said in a statement.

Fundamental test

The situation could pose a fundamental test of America’s rule of law. If the administration fails to comply with the emergency order, it is unclear how it might be enforced. The Constitution says that a president “shall take Care that the Laws be faithfully executed”, but courts have rarely been tested by a chief executive who has ignored their orders.

Federal officials have sometimes responded to adverse decisions with dawdling or grudging compliance. Outright disobedience is exceedingly rare. There has been no clear example of “open presidential defiance of court orders in the years since 1865”, according to a Harvard Law Review article published in 2018.

Saturday’s order came in response to a lawsuit filed on Friday by New York Attorney-General Letitia James along with 18 other Democratic state attorneys-general, charging that when Mr Trump had given Mr Musk the run of government computer systems, he had breached protections enshrined in the Constitution and “failed to faithfully execute the laws enacted by Congress”.

The lawsuit was joined by the attorneys-general of Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, North Carolina, Oregon, Rhode Island, Vermont and Wisconsin.

They said the president had given “virtually unfettered access” to the federal government’s most sensitive information to young aides who worked for Mr Musk, who runs a program the administration calls the Department of Government Efficiency, or DOGE.

While the group was supposedly assigned to cut costs, members are “attempting to access government data to support initiatives to block federal funds from reaching certain disfavoured beneficiaries”, according to the suit. Musk has publicly stated his intention to “recklessly freeze streams of federal funding without warning”, the suit said, pointing to his social media posts in recent days.

In her own social media post on Saturday, Ms James reiterated that members of the cost-cutting team “must destroy all records they’ve obtained” and added, “I’ve said before, and I’ll say it again: no one is above the law,” she wrote.

New Jersey’s attorney-general, Matthew J. Platkin, said in a post on Saturday that the injunction meant “the world’s richest man has been stopped from stealing your data”.

Efforts to reach press officers at the White House were not immediately successful.

In a statement on Thursday, after the attorneys-general said they would sue, a spokesperson for the president said that Mr Musk’s team was acting legally. “Slashing waste, fraud and abuse, and becoming better stewards of the American taxpayer’s hard-earned dollars might be a crime to Democrats, but it’s not a crime in a court of law,” said the spokesperson, Harrison Fields.

Although the court order mandates an immediate halt to Mr Musk’s employees’ access to the Treasury Department’s payment system, it was not immediately clear when or if they would fully comply. Nor was it clear how the attorneys-general would monitor the administration’s actions.

In a previous action, 23 attorneys-general sued Mr Trump’s freeze of federal grants and won a temporary pause on January 31, with a judge ordering the administration to stop withholding funds. However, on Friday, the coalition appealed to the judge again, saying that the money was still being withheld from states, grantees and programs.

Musk unconstrained

Mr Trump has had scant success in the courts in years past. His first administration succeeded in only about 23 per cent of the legal challenges against the actions of his agencies, a review found, while prior administrations won about 70 per cent of the time.

But Mr Trump’s new term is already a thing apart.

The administration’s “shock and awe” approach since he was inaugurated last month has seen new policies and actions arrive at breakneck speed. On his first day in office, Mr Trump pardoned members of the mob that attacked the Capitol on January 6, 2021. He has signed dozens of executive orders, withdrawn the country from international agreements and even tried to install himself as chair of the John F. Kennedy Centre for the Performing Arts in Washington.

The aggressive approach is beginning to be tested by scores of lawsuits on a host of issues, but the legal system’s ability to restrain the administration remains uncertain.

If federal officials fail to comply with the Saturday order limiting DOGE, the judge may hold them in contempt, said Daniel Richman, a Columbia Law School professor and a former federal prosecutor in New York City. Courts have done that in the past, he said, “albeit rarely.”

“A contempt citation can come with fines, more likely imposed on the officials rather than the government itself, and even possible imprisonment,” Mr Richman said.

In 2002, then-interior secretary Gale Norton was held in contempt for failing to fix the department’s management of billions of dollars in royalties earned on American Indian land. The following year, a federal appeals court found that she could not be held in criminal contempt for problems that existed before her tenure.

Although contempt findings can be “devoid of sanction, they nonetheless have a shaming effect”, which is often enough to spur officials to compliance, Nicholas Parrillo, a professor at Yale Law School, wrote in the 2018 Harvard Law Review article.

However, he wrote, the “rise of partisan polarisation could potentially fracture the pro-compliance community so badly that members of one party would refuse to acknowledge the shame of a contempt finding against a member of their own camp”.

Since Mr Trump entered office last month, Musk has so far been unconstrained. When DOGE first turned its attention to the Treasury Department, a top official refused to give members access, leading to a standoff. The official, David Lebryk, was put on leave before suddenly retiring.

Almost immediately, Mr Musk’s team was given access to the government’s most fundamental computer data, including the US Treasury Department’s payment system, which is used to disburse funds including Social Security benefits, veterans’ benefits and federal employee wages.

The system – which channels about 90 per cent of the payments for the US government, which spent about $US6.75 trillion last fiscal year – pays funds directly to people in the states as well as to state governments, the suit says.

Before Mr Trump took office last month, access was granted only to a limited number of career civil servants with security clearances, the suit said. But Mr Musk’s efforts had interrupted federal funding for health clinics, preschools and climate initiatives, according to the filing.

The money had already been allocated by Congress. The Constitution assigns to legislators the job of deciding government spending.

“President Trump does not have the power to give away Americans’ private information to anyone he chooses, and he cannot cut federal payments approved by Congress,” Ms James said in a statement. “Musk and DOGE have no authority to access Americans’ private information and some of our country’s most sensitive data.”

Here is the link:

https://www.afr.com/world/north-america/judge-extends-brake-on-elon-musk-s-treasury-raid-summons-trump-to-court-20250209-p5lanh

It will be interesting to see if the centre holds here and that if Mt Musk is contained in what he can actually do without due and proper process! The next month or two will be very interesting I believe!

My view is that Mr Musk should stick to making cars and rocket-ships which he seems pretty good at and let the system get on with what is has done for the last few hundred years!

Will be fun to see how it all plays out!

David.

It Is Fairly Obvious We Need To Be Making Sure The Health System Does Not Have A Harmful Sex Bias.

These appeared last week:

Labor invest in female health, argue system ‘wasn’t working for women’

Improved access to birth control and treatments for UTIs, menopause and endometriosis will reform care for a health area ‘shrouded in shame and stigma’.

James Dowling

9 February, 2025

The Albanese government will announce half a billion dollars in women’s health investments, highlighting improved access to contraception and menopause care, with changes set to take effect on either side of the federal election.

On Sunday, Minister for Women Katy Gallagher, Health Minister Mark Butler and Assistant Health Minister Ged Kearney will announce a $573 million swath of policies including new subsidised oral contraceptives, more endometriosis clinics, access to intra-uterine contraceptive devices and greater Medicare support for menopause treatments.

A portion of the announcements, namely newly subsidised medicines, will take effect next month, while longer term goals such as constructing endometriosis and pelvic pain clinics are commitments Labor would take to its second term if re-elected. A joint announcement said the health package was informed by recommendations from relevant senate inquiries and the National Women’s Health Advisory Council.

Mr Butler said the government’s independent medicine subsidy agency, the Pharmaceutical Benefits Scheme, had not kept pace with social progress in ensuring access to a multitude of contraceptives, while keeping hormone replacement therapies out of reach for many women.

“With no new contraceptive pill or menopausal hormone therapy added to the PBS in decades, it was clear the PBS wasn’t working for women,” he said. “That’s why I asked our medicines experts to find a way to right that wrong.”

“It’s about time Australian women had more choice, lower costs and better health care

“Today’s announcement is a tribute to all the Australian women who have worked so hard, for so long, to have their voices heard and acknowledged.”

Two new contraceptive pills, sold under the brand names Yaz and Yasmin, will be listed on the PBS from March. The Health Department estimates one in three Australian women currently pay for birth control outside of the PBS, citing a lack of new subsidies in more than 30 years.

It will cut annual prescription costs from $380 to $126.40, or $30.80 for concession card holders.

Also from March, three new HRT types will be subsidised: Prometrium, Estrogel and Estrogel Pro.

While the Health Department frequently cites the independence of the PBS, it confirmed Mr Butler personally requested the Pharmaceutical Benefits Advisory Committee consider supporting HRT and contraceptive subsidies.

“Women have asked government to take their healthcare seriously, and we have listened,” Senator Gallagher said.

“Our investment of more than half a billion dollars will deliver more choice, lower costs, and better healthcare for women at all stages of their lives.

“These changes could save women and their families thousands of dollars across their lifetimes.

“Whether it’s saving hundreds of dollars on contraceptives, opening more endo and pelvic pain clinics, or ensuring more reliable support for women going through menopause – this comprehensive package will deliver for millions of women and their families.”

Complimenting HRT access will be greater support for menopause health assessments under Medicare, along with a national awareness campaign, doctor training drive and new clinical guidelines to unify care. The rebate would take effect from July.

In May last year, Mr Butler announced more than $100 million in endometriosis supports through Medicare, with a new suite of endometriosis and pelvic pain clinics intended to build on this.

The construction of eleven new clinics will bring the national total to 33, while expanding their role to also assist in specialised care for menopausal and perimenopausal women.

Finally, the health package included a boost to Medicare rebates for IUDs and two national trials to ramp up access to treatment for uncomplicated urinary tract infections.

Australia’s IUD uptake tracks below comparative countries, at around 10 per cent compared to 12.5 per cent in New Zealand and 33 per cent in Sweden. By raising the rebate by 150 per cent and investing in eight specialised training centres, Labor hoped to drive up use while improving supplementary health outcomes from implants like reductions to heavy menstrual bleeding, endometriosis and period pain.

UTI treatment trials will begin from early next year, allowing concession card holders to receive free pharmacy consultations.

“From our first periods as young girls to menopause in older age, women’s health has been shrouded in shame and stigma. I’m proud to be part of an Albanese Labor Government that stands up for women and says this is not good enough, and it never has been,” Ms Kearney said.

“Women deserve choice and control when it comes to their healthcare needs, and they deserve a healthcare system that understands and responds to these needs as they change throughout their lives.

“This investment in women’s health of over half a billion dollars will shift the dial on an entrenched culture of medical misogyny – we’re talking about alleviating pain, reducing delays in diagnosis, avoiding unplanned pregnancies, and transforming menopause care.”

Health policies have been a central pillar in the early days of the Albanese government’s second term election campaign, driving up its contrast with the opposition through a revived ‘Mediscare’ tactic. It also comes after polling by the Nine Publishing newspapers indicated women were increasingly inclined to vote Labor, compared to a cohort of young men more partial to Peter Dutton.

Here is the link:

https://www.theaustralian.com.au/health/labor-invest-in-female-health-argue-system-wasnt-working-for-women/news-story/0518eea1490b9518243d217b177054b4

We also have reaction from the College of GPs:

RACGP applauds Albanese Government’s $573m women’s health package

The Royal Australian College of GPs has applauded the Federal Government’s $573.3 million package for women’s health which includes new funding for menopause health assessments and increased funding for long-acting reversible contraception (LARCs). 

The Albanese Government package announced today includes more funding for LARC insertion and removal, and to establish LARC training centres. It also includes new funding for menopause health assessments, the development of national guidelines for menopause and perimenopause, and for new generation contraceptive pills to be listed on the Pharmaceutical Benefits Scheme (PBS). 

RACGP President Dr Michael Wright said: “The RACGP has been calling for more funding for women’s health and we applaud the Albanese Government for this package, particularly funding for health assessments and LARCs. 

“We know cost-of-living is hitting women hard. Surveys show women are more likely to have delayed seeking essential healthcare due to costs than men. And, on top of this, medical misogyny is embedded in Medicare. 

“The current subsidy for Intrauterine Device (IUD) insertion is just $77, while a vasectomy, which is equally complex and time consuming, gets much more funding at $222. The RACGP spoke about this issue and the need for more funding with Health and Aged Care Assistant Minister Ged Kearney just last year. 

“Women across Australia need better access to affordable and comprehensive care for health issues like endometriosis, chronic pelvic pain, menopause, and perimenopause.  

New funding for menopause health assessments will immediately improve access to affordable and high-quality care from specialist GPs for those who need it. 

“The new generation contraceptive pills being added to the PBS will also give women greater options and choices. 

“There is no substitute for the quality care you get from a GP who knows you are your history. Everyone needs affordable access, no matter your gender, income, or where you live in Australia. 

“The RACGP has a comprehensive plan for accessible and affordable GP care, which includes a suite of initiatives for women’s health, which we’ll be releasing next week. As part of this, we have been calling for more funding for LARC insertion, and women’s health assessments.  

“Better funding women’s health including contraceptives and health assessments is an investment that will pay off. It will improve health and wellbeing, reduce pressure on our health system, and help reduce gender bias in our health system.” 

---

Media enquiries

Journalists and media outlets seeking comment and information from the RACGP can contact John Ronan, Ally Francis and Stuart Winthrope via:

RACGP Media

• 03 8699 0992
• media@racgp.org.au

Here is the link:

https://www.racgp.org.au/gp-news/media-releases/2025-media-releases/february-2025/racgp-applauds-albanese-government-s-573m-women-s

Somehow all this has the sincerity of big business applauding making profits – it goes without saying there should be a balanced and effective approach to female health issues – and given that women  outnumber men in medical graduations it seems pretty certain to happen without gratuitous press releases!

I must be getting too cynical in my dotage I guess! Anyway it is true there is some ground to be made up with female health issues with many years of under-investment in research etc. in female specific problems.

Let’s see what the next decade or two brings! Change will come for sure!

David.

AusHealthIT Poll Number 780 – Results – 9 February 2025.

Here are the results of the poll.

Do You Believe Donald Trump Has The Cognitive Capacity To Safely Be President Of The US?

Yes                                                                  3 (10%)

No                                                                  24(80%)

I Have No Idea                                               3 (10%)

Total No. Of Votes: 30

An interesting outcome with a huge majority not confident in Mr Trumps cognitive capacity!

Any insights on the poll are welcome, as a comment, as usual!

Very good voter turnout. 

3 of 30 who answered the poll admitted to not being sure about the answer to the question!

Again, many, many thanks to all those who voted! 

David.